Avient (AVNT) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
14 May, 2026Business overview and performance
Diversified global business with $3.3B in 2025 sales and $545M adjusted EBITDA, split 62% Color, Additives & Inks and 38% Specialty Engineered Materials.
2025 adjusted EPS reached $2.82 with a 16.7% adjusted EBITDA margin and 15 years of consecutive dividend growth.
Sales by region: 40% US/Canada, 36% EMEA, 18% Asia, 6% LATAM; end markets include packaging, consumer, industrial, transportation, and healthcare.
Strategic direction and growth drivers
Focus on margin expansion, above-market growth, and strong cash generation through productivity, innovation, and portfolio mix.
Strategy targets intersecting high-growth markets and secular trends, building scalable product platforms.
Growth vectors include composites for construction, electrification, defense, healthcare, and sustainability solutions.
Financial performance and targets
2025 organic revenue growth was flat overall, with Asia and LATAM up 3–4%, while US/Canada and EMEA declined.
2025 adjusted EBITDA margin expanded by 50 bps to 16.7%, and adjusted EPS grew 6% year-over-year.
Specialty Engineered Materials saw organic sales growth in healthcare, defense, and telecom, but margin declined 40 bps due to planned maintenance and investments.
Color, Additives & Inks experienced a 1% organic sales decline, offset by margin expansion from cost actions and productivity.
Latest events from Avient
- All voting items passed as 2025 financial targets were met and strategic growth plans outlined.AVNT
AGM 202614 May 2026 - Strong margin expansion and growth guidance driven by innovation and disciplined execution.AVNT
Investor presentation13 May 2026 - Q1 2026 adjusted EPS rose 9% to $0.83, with sales up and margins expanding.AVNT
Q1 20267 May 2026 - 2025 delivered margin and EPS growth; 2026 guidance targets further gains and investment.AVNT
Q4 202512 Apr 2026 - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.AVNT
Proxy filing27 Mar 2026 - 2026 proxy details innovation-driven strategy, board refresh, and performance-based executive pay.AVNT
Proxy filing27 Mar 2026 - Q2 2024 delivered 21% EPS growth, margin gains, and higher full-year guidance.AVNT
Q2 20242 Feb 2026 - Q3 sales up 8%, adjusted EPS up 14%, and full-year guidance raised amid broad-based growth.AVNT
Q3 202417 Jan 2026 - Targets 20%+ EBITDA margin and double-digit EPS growth through organic expansion in high-growth markets.AVNT
Investor Day 202411 Jan 2026